diphenhydramine

Key facts

Mechanism of action

Histamine H1 receptor antagonist

Approval history

1. 299IG301 Phase 3 · Biogen · IgA nephropathy
2. BN42082 Phase 3 · HOFFMANN-LA ROCHE · Relapsing Multiple Sclerosis (MS)
3. BN42083 Phase 3 · HOFFMANN-LA ROCHE · Primary Progressive Multiple Sclerosis (PPMS)
4. CA41705 Phase 3 · HOFFMANN-LA ROCHE · Lupus Nephritis (LN)
5. EFC15992 Phase 3 · Sanofi-Aventis U.S · Plasma cell myeloma
6. GCT3013-05 Phase 3 · Genmab · B-cell Lymphoma
7. M22-574 Phase 3 · AbbVie Deutschland GmbH · Relapsed or Refractory Multiple Myeloma (RRMM)
8. MN39158 Phase 3 · HOFFMANN-LA ROCHE · Multiple sclerosis (MS)

Frequently asked questions